Economics Generic Drug Prices Are Dropping, but Who Is This Really Benefiting? It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs. Charles Ornstein & Katie Thomas
News in Brief Corporate Incentives Make Insurers Favor Pushing Brand-Name Drugs Over Cheaper Generics Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics. Charles Ornstein & Katie Thomas
News in Brief Behind Pharmaceutical Companies’ Money-Back Guarantees Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected. Charles Ornstein & Katie Thomas